Proteins.1
PrivateLast Round
Pre Seed
Apr 16, 2026
Total Funding Raised
$5.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Proteins.1 operates in Healthcare & Life Sciences and is based in Espoo. Its latest recorded funding round was a Pre Seed round in April 2026.
Proteins.1 is a Finnish deeptech diagnostics company that develops a patented, physics-based single-molecule protein amplification platform for ultra-sensitive detection of biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proteins.1 Comparables
Compare Proteins.1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chronos DX | 86% | |
| Panacea Diagnostics | 81% | |
| Enumera Molecular | 81% |
For institutional investors. Book with your work email.
Proteins.1 Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Proteins.1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Pre Seed |
| Lifeline Ventures | Pre Seed |
| VTT Holding | Pre Seed |
| Cloudberry Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Raised $5.54M in a Pre Seed round.
For institutional investors. Book with your work email.
Proteins.1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Proteins.1's valuation, stock price, and market status.
Is Proteins.1 a public or private company?
Proteins.1 is a private company.
What is the current stock price of Proteins.1?
Proteins.1 is a private company, so its shares have no public market price. Caplight tracks Proteins.1's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Proteins.1 worth (valuation)?
Valuation information for Proteins.1 is not publicly available.
Can I buy Proteins.1 stock?
Proteins.1 shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Proteins.1's last funding round?
Proteins.1's most recent funding round was Pre Seed on April 16, 2026.
Who are the main investors in Proteins.1?
Key investors in Proteins.1 include Lifeline Ventures, Cloudberry Ventures.
Will Proteins.1 IPO soon?
No public IPO plans have been announced for Proteins.1.
How can I track Proteins.1 secondary market activity?
Caplight tracks bids, offers, and trades in Proteins.1's shares on secondary markets.